Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 601 AL 615

Evolving therapeutic interventions for the management and treatment of Alzheimer's disease

Ahmad F, Karan A, Sharma R, Sharma NS, Sundar V, Jayaraj R, Mukherjee S, DeCoster MA.

Ageing Res Rev. 2024 Mar;95:102229. doi: 10.1016/j.arr.2024.102229. Epub 2024 Feb 15.

Neurosteroids: A potential target for neuropsychiatric disorders

Wang M, Hu S, Fu X, Zhou H, Yang S, Yang C.

J Steroid Biochem Mol Biol. 2024 May;239:106485. doi: 10.1016/j.jsbmb.2024.106485. Epub 2024 Feb 17.

Mesenchymal stem cell-derived extracellular vesicles: A novel promising neuroprotective agent for Alzheimer's disease

Chang J, Feng Z, Li Y, Lv H, Liu S, Luo Y, Hao N, Zhao L, Liu J.

Biochem Pharmacol. 2024 Apr;222:116064. doi: 10.1016/j.bcp.2024.116064. Epub 2024 Feb 17.

Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer's disease

Cheng F, Wang F, Tang J, Zhou Y, Fu Z, Zhang P, Haines JL, Leverenz JB, Gan L, Hu J, Rosen-Zvi M, Pieper AA, Cummings J.

Cell Rep Med. 2024 Feb 20;5(2):101379. doi: 10.1016/j.xcrm.2023.101379.

Monoclonal antibody therapy for Alzheimer's disease focusing on intracerebral targets

Gu X, Qi L, Qi Q, Zhou J, Chen S, Wang L.

Biosci Trends. 2024 Mar 19;18(1):49-65. doi: 10.5582/bst.2023.01288. Epub 2024 Feb 21.

Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer's Disease Drug Determination

Ivanov A, Shamagsumova R, Larina M, Evtugyn G.

Biosensors (Basel). 2024 Feb 9;14(2):93. doi: 10.3390/bios14020093.

Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia

Greenblatt CL, Lathe R.

J Alzheimers Dis. 2024;98(2):361-372. doi: 10.3233/JAD-231323.

Comorbidity Genes of Alzheimer's Disease and Type 2 Diabetes Associated with Memory and Cognitive Function

Cho SB.

Int J Mol Sci. 2024 Feb 12;25(4):2211. doi: 10.3390/ijms25042211.

Interactions between nanoparticles and pathological changes of vascular in Alzheimer's disease

Lei T, Yang Z, Li H, Qin M, Gao H.

Adv Drug Deliv Rev. 2024 Apr;207:115219. doi: 10.1016/j.addr.2024.115219. Epub 2024 Feb 23.

Effectiveness of Novel Drug Delivery System using Curcumin in Alzheimer's Disease

Aswar U, Rathod K, Mathure D.

Cent Nerv Syst Agents Med Chem. 2024;24(3):281-293. doi: 10.2174/0118715249279534240214111155.

More failure with solanezumab - this time in preclinical Alzheimer's disease

Doggrell SA.

Expert Opin Biol Ther. 2024 Mar;24(3):119-123. doi: 10.1080/14712598.2024.2325551. Epub 2024 Mar 3.

The Unveiling of Therapeutic Targets for Alzheimer's Disease: An Integrative Review

Madar P, Nagalapur P, Chaudhari S, Sharma D, Koparde A, Buchade R, Kshirsagar S, Uttekar P, Jadhav S, Chaudhari P.

Curr Top Med Chem. 2024;24(10):850-868. doi: 10.2174/0115680266282492240220101049.

Exploring Potential of Nano-formulations in the Treatment of Alzheimer's Disease through Nasal Route

Tekade A, Kadam P, Jagdale S, Surwade S, Gaikwad A, Pawar P, Shinde R.

Curr Alzheimer Res. 2024;21(10):693-709. doi: 10.2174/0115672050290462240222092303.

Brain Banking in Dementia Studies

Isik AT, Kaya D, Gokden M.

Methods Mol Biol. 2024;2785:287-295. doi: 10.1007/978-1-0716-3774-6_17.

Aβ-binding with alcohol dehydrogenase drives Alzheimer's disease pathogenesis: A review

Ye Z, Liu Y, Jin X, Wu Y, Zhao H, Gao T, Deng Q, Cheng J, Lin J, Tong Z.

Int J Biol Macromol. 2024 Apr;264(Pt 2):130580. doi: 10.1016/j.ijbiomac.2024.130580. Epub 2024 Mar 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias